Subjects with high fasting insulin also have higher postprandial GLP-1 and glucagon levels than controls with lower insulin
Little is known about postprandial release of serum ghrelin, glucagon, and glucagon-like peptide-1 (GLP-1) in relation with differing fasting insulin levels. We hypothesized that these hormones are affected by insulin resistance, and hence, we compared different postprandial responses of GLP-1, gluc...
Saved in:
Published in | Nutrition research (New York, N.Y.) Vol. 72; pp. 111 - 120 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.12.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 0271-5317 1879-0739 1879-0739 |
DOI | 10.1016/j.nutres.2019.10.009 |
Cover
Abstract | Little is known about postprandial release of serum ghrelin, glucagon, and glucagon-like peptide-1 (GLP-1) in relation with differing fasting insulin levels. We hypothesized that these hormones are affected by insulin resistance, and hence, we compared different postprandial responses of GLP-1, glucagon, and ghrelin in subjects with relatively high (RHI) or relatively low (RLI) fasting insulin levels. The trial was a randomized crossover study with 4 different meal conditions. Fourteen nonobese or obese, healthy, men and 14 women were randomly assigned to the order of supervised intake of a 750 kcal drink with the same protein contents but with 20 energy-percent (E%) or 55 E% from carbohydrates, and the remaining energy from fat. Participants were also randomized to consume the drinks as 1 large beverage or as five 150-kcal portions every 30 minutes. The 28 subjects were divided into 2 equally sized groups based on fasting insulin levels. Statistics were done with general linear mixed model. Fasting insulin levels were 3-fold higher in the group with RHI compared with the RLI group (RHI: 1004 ± 510 pg/mL, RLI: 324 ± 123 pg/mL, P < .0005). Serum GLP-1 was highest in the RHI group after both single meals and after 5 drinks and following high- and low-carbohydrate meals (both P ≤ .002), and this was the case also for glucagon levels (both P ≤ .018), whereas ghrelin levels did not differ between groups. Thus, subjects with RHI displayed both higher postprandial serum GLP-1 and glucagon than the participants with RLI, suggesting that glucagon could play a role in the advent of dysglycemia by insulin resistance. |
---|---|
AbstractList | Little is known about postprandial release of serum ghrelin, glucagon, and glucagon-like peptide-1 (GLP-1) in relation with differing fasting insulin levels. We hypothesized that these hormones are affected by insulin resistance, and hence, we compared different postprandial responses of GLP-1, glucagon, and ghrelin in subjects with relatively high (RHI) or relatively low (RLI) fasting insulin levels. The trial was a randomized crossover study with 4 different meal conditions. Fourteen nonobese or obese, healthy, men and 14 women were randomly assigned to the order of supervised intake of a 750 kcal drink with the same protein contents but with 20 energy-percent (E%) or 55 E% from carbohydrates, and the remaining energy from fat. Participants were also randomized to consume the drinks as 1 large beverage or as five 150-kcal portions every 30 minutes. The 28 subjects were divided into 2 equally sized groups based on fasting insulin levels. Statistics were done with general linear mixed model. Fasting insulin levels were 3-fold higher in the group with RHI compared with the RLI group (RHI: 1004 ± 510 pg/mL, RLI: 324 ± 123 pg/mL, P < .0005). Serum GLP-1 was highest in the RHI group after both single meals and after 5 drinks and following high- and low-carbohydrate meals (both P ≤ .002), and this was the case also for glucagon levels (both P ≤ .018), whereas ghrelin levels did not differ between groups. Thus, subjects with RHI displayed both higher postprandial serum GLP-1 and glucagon than the participants with RLI, suggesting that glucagon could play a role in the advent of dysglycemia by insulin resistance. Little is known about postprandial release of serum ghrelin, glucagon, and glucagon-like peptide-1 (GLP-1) in relation with differing fasting insulin levels. We hypothesized that these hormones are affected by insulin resistance, and hence, we compared different postprandial responses of GLP-1, glucagon, and ghrelin in subjects with relatively high (RHI) or relatively low (RLI) fasting insulin levels. The trial was a randomized crossover study with 4 different meal conditions. Fourteen nonobese or obese, healthy, men and 14 women were randomly assigned to the order of supervised intake of a 750 kcal drink with the same protein contents but with 20 energy-percent (E%) or 55 E% from carbohydrates, and the remaining energy from fat. Participants were also randomized to consume the drinks as 1 large beverage or as five 150-kcal portions every 30 minutes. The 28 subjects were divided into 2 equally sized groups based on fasting insulin levels. Statistics were done with general linear mixed model. Fasting insulin levels were 3-fold higher in the group with RHI compared with the RLI group (RHI: 1004 +/- 510 pg/mL, RLI: 324 +/- 123 pg/mL, P amp;lt; .0005). Serum GLP-1 was highest in the RHI group after both single meals and after 5 drinks and following high- and low-carbohydrate meals (both P amp;lt;= .002), and this was the case also for glucagon levels (both P amp;lt;= .018), whereas ghrelin levels did not differ between groups. Thus, subjects with RHI displayed both higher postprandial serum GLP-1 and glucagon than the participants with RLI, suggesting that glucagon could play a role in the advent of dysglycemia by insulin resistance. (C) 2019 Elsevier Inc. All rights reserved. Little is known about postprandial release of serum ghrelin, glucagon, and glucagon-like peptide-1 (GLP-1) in relation with differing fasting insulin levels. We hypothesized that these hormones are affected by insulin resistance, and hence, we compared different postprandial responses of GLP-1, glucagon, and ghrelin in subjects with relatively high (RHI) or relatively low (RLI) fasting insulin levels. The trial was a randomized crossover study with 4 different meal conditions. Fourteen nonobese or obese, healthy, men and 14 women were randomly assigned to the order of supervised intake of a 750 kcal drink with the same protein contents but with 20 energy-percent (E%) or 55 E% from carbohydrates, and the remaining energy from fat. Participants were also randomized to consume the drinks as 1 large beverage or as five 150-kcal portions every 30 minutes. The 28 subjects were divided into 2 equally sized groups based on fasting insulin levels. Statistics were done with general linear mixed model. Fasting insulin levels were 3-fold higher in the group with RHI compared with the RLI group (RHI: 1004 ± 510 pg/mL, RLI: 324 ± 123 pg/mL, P < .0005). Serum GLP-1 was highest in the RHI group after both single meals and after 5 drinks and following high- and low-carbohydrate meals (both P ≤ .002), and this was the case also for glucagon levels (both P ≤ .018), whereas ghrelin levels did not differ between groups. Thus, subjects with RHI displayed both higher postprandial serum GLP-1 and glucagon than the participants with RLI, suggesting that glucagon could play a role in the advent of dysglycemia by insulin resistance.Little is known about postprandial release of serum ghrelin, glucagon, and glucagon-like peptide-1 (GLP-1) in relation with differing fasting insulin levels. We hypothesized that these hormones are affected by insulin resistance, and hence, we compared different postprandial responses of GLP-1, glucagon, and ghrelin in subjects with relatively high (RHI) or relatively low (RLI) fasting insulin levels. The trial was a randomized crossover study with 4 different meal conditions. Fourteen nonobese or obese, healthy, men and 14 women were randomly assigned to the order of supervised intake of a 750 kcal drink with the same protein contents but with 20 energy-percent (E%) or 55 E% from carbohydrates, and the remaining energy from fat. Participants were also randomized to consume the drinks as 1 large beverage or as five 150-kcal portions every 30 minutes. The 28 subjects were divided into 2 equally sized groups based on fasting insulin levels. Statistics were done with general linear mixed model. Fasting insulin levels were 3-fold higher in the group with RHI compared with the RLI group (RHI: 1004 ± 510 pg/mL, RLI: 324 ± 123 pg/mL, P < .0005). Serum GLP-1 was highest in the RHI group after both single meals and after 5 drinks and following high- and low-carbohydrate meals (both P ≤ .002), and this was the case also for glucagon levels (both P ≤ .018), whereas ghrelin levels did not differ between groups. Thus, subjects with RHI displayed both higher postprandial serum GLP-1 and glucagon than the participants with RLI, suggesting that glucagon could play a role in the advent of dysglycemia by insulin resistance. |
Author | Nystrom, Fredrik H Vilhelmsson, Nathalie Albinsson-Stenholm, Erina Bergsén, Johannes Ingves, Simon Guldbrand, Hans |
Author_xml | – sequence: 1 givenname: Erina surname: Albinsson-Stenholm fullname: Albinsson-Stenholm, Erina – sequence: 2 givenname: Johannes surname: Bergsén fullname: Bergsén, Johannes – sequence: 3 givenname: Simon surname: Ingves fullname: Ingves, Simon – sequence: 4 givenname: Nathalie surname: Vilhelmsson fullname: Vilhelmsson, Nathalie – sequence: 5 givenname: Hans surname: Guldbrand fullname: Guldbrand, Hans – sequence: 6 givenname: Fredrik H surname: Nystrom fullname: Nystrom, Fredrik H email: fredrik.h.nystrom@liu.se, Fredrik.h.nystrom@gmail.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31759769$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-163259$$DView record from Swedish Publication Index |
BookMark | eNqNkl1vFCEUhompsdvqPzCGS29mBeaDHWNMmmqrySaa-HFLGObMDCsLIzC7afzzZZ2tF71ZrwiH931CeLhAZ9ZZQOglJUtKaPVms7RT9BCWjNA6jZaE1E_Qgq54nRGe12doQRinWZlTfo4uQtgQQjnN82foPI3Kmlf1Av35NjUbUDHgvY4DHnQ_4E6GqG2PtQ2T0RZLExwe5A7-HoPHowtx9NK2Whp8u_6aUZw2uDeTkr2z2MAOTMBxkBYrZ6N35sg3bp_6R_Bz9LRLbHhxXC_Rj5uP368_Zesvt5-vr9aZKnMWs46UspSdLGAFhBZsVfCqU7KiqlEtZV3O6g5WRVUoVqmuoSXt8po1RBUsJzw9xSXKZm7Ywzg1YvR6K_2dcFKLD_rnlXC-F0ZPglY5K-uUfz3nR-9-TxCi2OqgwBhpwU1BsLxkRVFyQv8jSnnNacmLFH11jE7NFtp_t3hwkQJv54DyLgQPnVA6yqgPDyi1EZSIg3ixEbN4cRB_mCbxqVw8Kj_wT9Tez7XkC3YavAhKg1XQap9-hWidPgV49wigklmtpPkFd6fr92OD360 |
CitedBy_id | crossref_primary_10_3390_ijms24108937 |
Cites_doi | 10.1111/dom.12935 10.1038/ejcn.2014.208 10.1155/2010/710852 10.1002/dmrr.2501 10.3945/ajcn.115.106799 10.1210/jc.2013-4010 10.1016/j.peptides.2017.12.015 10.1080/07435800.2017.1379023 10.1016/j.nut.2014.10.002 10.1016/S2213-8587(15)00482-9 10.1016/j.biochi.2017.10.004 10.1097/MCO.0000000000000101 10.1055/a-0746-4014 10.4239/wjd.v7.i20.572 10.3390/molecules23061483 10.1111/j.2040-1124.2010.00022.x 10.3109/13813455.2013.812664 10.1016/j.peptides.2017.04.011 10.1056/NEJM199205143262003 10.1530/EJE-19-0173 10.1038/nutd.2013.20 10.14310/horm.2002.1672 10.1136/bmj.k4583 10.1507/endocrj.K09E-269 10.1042/CS20150154 10.1016/j.mayocp.2017.12.003 10.1038/s41574-018-0016-2 10.1186/s12933-016-0440-3 10.2337/db16-0240 10.1016/j.peptides.2017.11.016 |
ContentType | Journal Article |
Copyright | 2019 Elsevier Inc. Copyright © 2019 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2019 Elsevier Inc. – notice: Copyright © 2019 Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION NPM 7X8 7S9 L.6 ABXSW ADTPV AOWAS D8T DG8 ZZAVC |
DOI | 10.1016/j.nutres.2019.10.009 |
DatabaseName | CrossRef PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic SWEPUB Linköpings universitet full text SwePub SwePub Articles SWEPUB Freely available online SWEPUB Linköpings universitet SwePub Articles full text |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | PubMed AGRICOLA MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Diet & Clinical Nutrition Statistics |
EISSN | 1879-0739 |
EndPage | 120 |
ExternalDocumentID | oai_DiVA_org_liu_163259 31759769 10_1016_j_nutres_2019_10_009 S0271531719305214 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29N 4.4 457 4CK 4G. 53G 5RE 5VS 7-5 71M 85S 8P~ 9JM AAEDT AAEDW AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABFNM ABGSF ABJNI ABMAC ABMZM ABUDA ABWVN ABXDB ACDAQ ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADUVX AEBSH AEHWI AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGRDE AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDZ HMK HMO HVGLF HZ~ IHE J1W K-O KOM LZ1 M29 M41 MO0 MVM N9A O-L O9- OAUVE OC. ON0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSU SSZ T5K WH7 WUQ Z5R ZGI ZXP ~G- ~KM AACTN AAIAV ABLVK ABYKQ AFCTW AFKWA AJBFU AJOXV AMFUW DOVZS EFLBG LCYCR AAYXX AGRNS CITATION NPM 7X8 ACLOT ~HD 7S9 L.6 ABXSW ADTPV AOWAS D8T DG8 ZZAVC |
ID | FETCH-LOGICAL-c532t-f05a5afa4e8e01428476fca61cbcd12f329fe8464c26cfb151f392b0c42307073 |
IEDL.DBID | .~1 |
ISSN | 0271-5317 1879-0739 |
IngestDate | Tue Sep 09 23:08:23 EDT 2025 Sun Sep 28 07:40:20 EDT 2025 Sat Sep 27 19:31:33 EDT 2025 Wed Feb 19 02:32:17 EST 2025 Thu Apr 24 22:49:24 EDT 2025 Tue Jul 01 03:50:15 EDT 2025 Fri Feb 23 02:49:21 EST 2024 Tue Aug 26 18:28:03 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Meal distribution EE GLP-1 Glucagon RLI AUC Glucagon-like peptide-1 RHI Ghrelin LC Satiety SEM HC Carbohydrate content BMI |
Language | English |
License | Copyright © 2019 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c532t-f05a5afa4e8e01428476fca61cbcd12f329fe8464c26cfb151f392b0c42307073 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
OpenAccessLink | https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-163259 |
PMID | 31759769 |
PQID | 2317971574 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | swepub_primary_oai_DiVA_org_liu_163259 proquest_miscellaneous_2352445701 proquest_miscellaneous_2317971574 pubmed_primary_31759769 crossref_citationtrail_10_1016_j_nutres_2019_10_009 crossref_primary_10_1016_j_nutres_2019_10_009 elsevier_sciencedirect_doi_10_1016_j_nutres_2019_10_009 elsevier_clinicalkey_doi_10_1016_j_nutres_2019_10_009 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-12-01 |
PublicationDateYYYYMMDD | 2019-12-01 |
PublicationDate_xml | – month: 12 year: 2019 text: 2019-12-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Nutrition research (New York, N.Y.) |
PublicationTitleAlternate | Nutr Res |
PublicationYear | 2019 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Faerch, Vistisen, Pacini, Torekov, Johansen, Witte (bb0115) 2016; 65 Andersen, Lund, Knop, Vilsboll (bb0030) 2018; 14 Ceriello, Genovese, Mannucci, Gronda (bb0085) 2016; 15 Girard (bb0070) 2017; 143 Gutniak, Orskov, Holst, Ahren, Efendic (bb0120) 1992; 326 Mihalache, Gherasim, Nita, Ungureanu, Padureanu, Gavril (bb0055) 2016; 15 Temizkan, Deyneli, Yasar, Arpa, Gunes, Yazici (bb0020) 2015; 69 Seino, Fukushima, Yabe (bb0100) 2010; 1 van Raalte, Verchere (bb0005) 2017; 19 Prodam, Monzani, Ricotti, Marolda, Bellone, Aimaretti (bb0045) 2014; 99 Jezek, Jaburek, Holendova, Plecita-Hlavata (bb0010) 2018; 23 Benedict, Barclay, Ott, Oster, Hallschmid (bb0155) 2013; 3 Lee, Yabe, Nohtomi, Takada, Morita, Seino (bb0105) 2010; 57 Urbano, Di Pino, Scicali, Filippello, Di Mauro, Scamporrino (bb0125) 2019 Koliaki, Kokkinos, Tentolouris, Katsilambros (bb0060) 2010; 2010 Pinkney (bb0050) 2014; 17 Mandoe, Hansen, Hartmann, Rehfeld, Holst, Hansen (bb0015) 2015; 102 Bounias, Pouliliou, Tripsianis, Antonoglou, Papazoglou, Maltezos (bb0110) 2018; 50 Ingves, Vilhelmsson, Strom, Fredrikson, Guldbrand, Nystrom (bb0090) 2017; 93 Haedersdal, Lund, Knop, Vilsboll (bb0075) 2018; 93 Malik, Roohi (bb0135) 2018; 32 Anandhakrishnan, Korbonits (bb0025) 2016; 7 Nauck, Meier (bb0040) 2016; 4 Kuhre, Holst, Kappe (bb0140) 2016; 130 Nystrom, Quon (bb0145) 2015; 31 Ebbeling, Feldman, Klein, Wong, Bielak, Steltz (bb0150) 2018; 363 Yoo, Yang, Lee, Koh (bb0095) 2018; 43 Tasyurek, Altunbas, Balci, Sanlioglu (bb0035) 2014; 30 Wewer Albrechtsen (bb0080) 2018; 100 Poher, Tschop, Muller (bb0065) 2018; 100 Opinto, Natalicchio, Marchetti (bb0130) 2013; 119 Poher (10.1016/j.nutres.2019.10.009_bb0065) 2018; 100 Girard (10.1016/j.nutres.2019.10.009_bb0070) 2017; 143 Seino (10.1016/j.nutres.2019.10.009_bb0100) 2010; 1 Pinkney (10.1016/j.nutres.2019.10.009_bb0050) 2014; 17 Haedersdal (10.1016/j.nutres.2019.10.009_bb0075) 2018; 93 Ceriello (10.1016/j.nutres.2019.10.009_bb0085) 2016; 15 Wewer Albrechtsen (10.1016/j.nutres.2019.10.009_bb0080) 2018; 100 Anandhakrishnan (10.1016/j.nutres.2019.10.009_bb0025) 2016; 7 Mihalache (10.1016/j.nutres.2019.10.009_bb0055) 2016; 15 Andersen (10.1016/j.nutres.2019.10.009_bb0030) 2018; 14 Opinto (10.1016/j.nutres.2019.10.009_bb0130) 2013; 119 Faerch (10.1016/j.nutres.2019.10.009_bb0115) 2016; 65 Yoo (10.1016/j.nutres.2019.10.009_bb0095) 2018; 43 Prodam (10.1016/j.nutres.2019.10.009_bb0045) 2014; 99 Urbano (10.1016/j.nutres.2019.10.009_bb0125) 2019 van Raalte (10.1016/j.nutres.2019.10.009_bb0005) 2017; 19 Gutniak (10.1016/j.nutres.2019.10.009_bb0120) 1992; 326 Nystrom (10.1016/j.nutres.2019.10.009_bb0145) 2015; 31 Ebbeling (10.1016/j.nutres.2019.10.009_bb0150) 2018; 363 Tasyurek (10.1016/j.nutres.2019.10.009_bb0035) 2014; 30 Ingves (10.1016/j.nutres.2019.10.009_bb0090) 2017; 93 Bounias (10.1016/j.nutres.2019.10.009_bb0110) 2018; 50 Malik (10.1016/j.nutres.2019.10.009_bb0135) 2018; 32 Benedict (10.1016/j.nutres.2019.10.009_bb0155) 2013; 3 Kuhre (10.1016/j.nutres.2019.10.009_bb0140) 2016; 130 Jezek (10.1016/j.nutres.2019.10.009_bb0010) 2018; 23 Temizkan (10.1016/j.nutres.2019.10.009_bb0020) 2015; 69 Koliaki (10.1016/j.nutres.2019.10.009_bb0060) 2010; 2010 Mandoe (10.1016/j.nutres.2019.10.009_bb0015) 2015; 102 Nauck (10.1016/j.nutres.2019.10.009_bb0040) 2016; 4 Lee (10.1016/j.nutres.2019.10.009_bb0105) 2010; 57 |
References_xml | – volume: 130 start-page: 79 year: 2016 end-page: 91 ident: bb0140 article-title: The regulation of function, growth and survival of GLP-1-producing L-cells publication-title: Clin Sci (Lond) – volume: 50 start-page: 822 year: 2018 end-page: 826 ident: bb0110 article-title: Ghrelin levels in basal conditions and during glucose tolerance test in prediabetic and diabetic patients publication-title: Horm Metab Res – volume: 14 start-page: 390 year: 2018 end-page: 403 ident: bb0030 article-title: Glucagon-like peptide 1 in health and disease publication-title: Nat Rev Endocrinol – volume: 99 start-page: 1556 year: 2014 end-page: 1568 ident: bb0045 article-title: Systematic review of ghrelin response to food intake in pediatric age, from neonates to adolescents publication-title: J Clin Endocrinol Metab – volume: 31 start-page: 244 year: 2015 end-page: 247 ident: bb0145 article-title: Man shall not live by bread alone publication-title: Nutrition – volume: 32 start-page: 1171 year: 2018 end-page: 1176 ident: bb0135 article-title: GLP-1, a powerful physiological incretin: an update publication-title: J Biol Regul Homeost Agents – volume: 65 start-page: 3473 year: 2016 end-page: 3481 ident: bb0115 article-title: Insulin resistance is accompanied by increased fasting glucagon and delayed glucagon suppression in individuals with normal and impaired glucose regulation publication-title: Diabetes – volume: 17 start-page: 497 year: 2014 end-page: 502 ident: bb0050 article-title: The role of ghrelin in metabolic regulation publication-title: Curr Opin Clin Nutr Metab Care – volume: 23 year: 2018 ident: bb0010 article-title: Fatty acid-stimulated insulin secretion vs. Lipotoxicity publication-title: Molecules – volume: 1 start-page: 8 year: 2010 end-page: 23 ident: bb0100 article-title: GIP and GLP-1, the two incretin hormones: similarities and differences publication-title: J Diabetes Investig – volume: 93 start-page: 217 year: 2018 end-page: 239 ident: bb0075 article-title: The role of glucagon in the pathophysiology and treatment of type 2 diabetes publication-title: Mayo Clin Proc – volume: 57 start-page: 119 year: 2010 end-page: 126 ident: bb0105 article-title: Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes publication-title: Endocr J – volume: 69 start-page: 162 year: 2015 end-page: 166 ident: bb0020 article-title: Sucralose enhances GLP-1 release and lowers blood glucose in the presence of carbohydrate in healthy subjects but not in patients with type 2 diabetes publication-title: Eur J Clin Nutr – volume: 93 start-page: 20 year: 2017 end-page: 26 ident: bb0090 article-title: A randomized cross-over study of the effects of macronutrient composition and meal frequency on GLP-1, ghrelin and energy expenditure in humans publication-title: Peptides – volume: 119 start-page: 170 year: 2013 end-page: 178 ident: bb0130 article-title: Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity publication-title: Arch Physiol Biochem – volume: 3 start-page: e78 year: 2013 ident: bb0155 article-title: Acute sleep deprivation delays the glucagon-like peptide 1 peak response to breakfast in healthy men publication-title: Nutr Diabetes – volume: 7 start-page: 572 year: 2016 end-page: 598 ident: bb0025 article-title: Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity publication-title: World J Diabetes – year: 2019 ident: bb0125 article-title: Impaired glucagon suppression and reduced insulin sensitivity in subjects with prediabetes undergoing atorvastatin therapy publication-title: Eur J Endocrinol – volume: 43 start-page: 47 year: 2018 end-page: 54 ident: bb0095 article-title: Postmeal increment in intact glucagon-like peptide 1 level, but not intact glucose-dependent insulinotropic polypeptide levels, is inversely associated with metabolic syndrome in patients with type 2 diabetes publication-title: Endocr Res – volume: 102 start-page: 548 year: 2015 end-page: 555 ident: bb0015 article-title: The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humans publication-title: Am J Clin Nutr – volume: 15 start-page: 186 year: 2016 end-page: 196 ident: bb0055 article-title: Effects of ghrelin in energy balance and body weight homeostasis publication-title: Hormones (Athens) – volume: 363 start-page: k4583 year: 2018 ident: bb0150 article-title: Effects of a low carbohydrate diet on energy expenditure during weight loss maintenance: randomized trial publication-title: BMJ – volume: 2010 year: 2010 ident: bb0060 article-title: The effect of ingested macronutrients on postprandial ghrelin response: a critical review of existing literature data publication-title: Int J Pept – volume: 326 start-page: 1316 year: 1992 end-page: 1322 ident: bb0120 article-title: Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus publication-title: N Engl J Med – volume: 19 start-page: 1205 year: 2017 end-page: 1213 ident: bb0005 article-title: Improving glycaemic control in type 2 diabetes: stimulate insulin secretion or provide beta-cell rest? publication-title: Diabetes Obes Metab – volume: 100 start-page: 236 year: 2018 end-page: 242 ident: bb0065 article-title: Ghrelin regulation of glucose metabolism publication-title: Peptides – volume: 30 start-page: 354 year: 2014 end-page: 371 ident: bb0035 article-title: Incretins: their physiology and application in the treatment of diabetes mellitus publication-title: Diabetes Metab Res Rev – volume: 100 start-page: 42 year: 2018 end-page: 47 ident: bb0080 article-title: Glucagon receptor signaling in metabolic diseases publication-title: Peptides – volume: 15 start-page: 123 year: 2016 ident: bb0085 article-title: Glucagon and heart in type 2 diabetes: new perspectives publication-title: Cardiovasc Diabetol – volume: 4 start-page: 525 year: 2016 end-page: 536 ident: bb0040 article-title: The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions publication-title: Lancet Diabetes Endocrinol – volume: 143 start-page: 33 year: 2017 end-page: 36 ident: bb0070 article-title: Glucagon, a key factor in the pathophysiology of type 2 diabetes publication-title: Biochimie – volume: 19 start-page: 1205 year: 2017 ident: 10.1016/j.nutres.2019.10.009_bb0005 article-title: Improving glycaemic control in type 2 diabetes: stimulate insulin secretion or provide beta-cell rest? publication-title: Diabetes Obes Metab doi: 10.1111/dom.12935 – volume: 69 start-page: 162 year: 2015 ident: 10.1016/j.nutres.2019.10.009_bb0020 article-title: Sucralose enhances GLP-1 release and lowers blood glucose in the presence of carbohydrate in healthy subjects but not in patients with type 2 diabetes publication-title: Eur J Clin Nutr doi: 10.1038/ejcn.2014.208 – volume: 2010 year: 2010 ident: 10.1016/j.nutres.2019.10.009_bb0060 article-title: The effect of ingested macronutrients on postprandial ghrelin response: a critical review of existing literature data publication-title: Int J Pept doi: 10.1155/2010/710852 – volume: 30 start-page: 354 year: 2014 ident: 10.1016/j.nutres.2019.10.009_bb0035 article-title: Incretins: their physiology and application in the treatment of diabetes mellitus publication-title: Diabetes Metab Res Rev doi: 10.1002/dmrr.2501 – volume: 102 start-page: 548 year: 2015 ident: 10.1016/j.nutres.2019.10.009_bb0015 article-title: The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humans publication-title: Am J Clin Nutr doi: 10.3945/ajcn.115.106799 – volume: 99 start-page: 1556 year: 2014 ident: 10.1016/j.nutres.2019.10.009_bb0045 article-title: Systematic review of ghrelin response to food intake in pediatric age, from neonates to adolescents publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2013-4010 – volume: 100 start-page: 236 year: 2018 ident: 10.1016/j.nutres.2019.10.009_bb0065 article-title: Ghrelin regulation of glucose metabolism publication-title: Peptides doi: 10.1016/j.peptides.2017.12.015 – volume: 43 start-page: 47 year: 2018 ident: 10.1016/j.nutres.2019.10.009_bb0095 article-title: Postmeal increment in intact glucagon-like peptide 1 level, but not intact glucose-dependent insulinotropic polypeptide levels, is inversely associated with metabolic syndrome in patients with type 2 diabetes publication-title: Endocr Res doi: 10.1080/07435800.2017.1379023 – volume: 31 start-page: 244 year: 2015 ident: 10.1016/j.nutres.2019.10.009_bb0145 article-title: Man shall not live by bread alone publication-title: Nutrition doi: 10.1016/j.nut.2014.10.002 – volume: 4 start-page: 525 year: 2016 ident: 10.1016/j.nutres.2019.10.009_bb0040 article-title: The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(15)00482-9 – volume: 143 start-page: 33 year: 2017 ident: 10.1016/j.nutres.2019.10.009_bb0070 article-title: Glucagon, a key factor in the pathophysiology of type 2 diabetes publication-title: Biochimie doi: 10.1016/j.biochi.2017.10.004 – volume: 17 start-page: 497 year: 2014 ident: 10.1016/j.nutres.2019.10.009_bb0050 article-title: The role of ghrelin in metabolic regulation publication-title: Curr Opin Clin Nutr Metab Care doi: 10.1097/MCO.0000000000000101 – volume: 50 start-page: 822 year: 2018 ident: 10.1016/j.nutres.2019.10.009_bb0110 article-title: Ghrelin levels in basal conditions and during glucose tolerance test in prediabetic and diabetic patients publication-title: Horm Metab Res doi: 10.1055/a-0746-4014 – volume: 7 start-page: 572 year: 2016 ident: 10.1016/j.nutres.2019.10.009_bb0025 article-title: Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity publication-title: World J Diabetes doi: 10.4239/wjd.v7.i20.572 – volume: 23 year: 2018 ident: 10.1016/j.nutres.2019.10.009_bb0010 article-title: Fatty acid-stimulated insulin secretion vs. Lipotoxicity publication-title: Molecules doi: 10.3390/molecules23061483 – volume: 1 start-page: 8 year: 2010 ident: 10.1016/j.nutres.2019.10.009_bb0100 article-title: GIP and GLP-1, the two incretin hormones: similarities and differences publication-title: J Diabetes Investig doi: 10.1111/j.2040-1124.2010.00022.x – volume: 119 start-page: 170 year: 2013 ident: 10.1016/j.nutres.2019.10.009_bb0130 article-title: Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity publication-title: Arch Physiol Biochem doi: 10.3109/13813455.2013.812664 – volume: 93 start-page: 20 year: 2017 ident: 10.1016/j.nutres.2019.10.009_bb0090 article-title: A randomized cross-over study of the effects of macronutrient composition and meal frequency on GLP-1, ghrelin and energy expenditure in humans publication-title: Peptides doi: 10.1016/j.peptides.2017.04.011 – volume: 326 start-page: 1316 year: 1992 ident: 10.1016/j.nutres.2019.10.009_bb0120 article-title: Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus publication-title: N Engl J Med doi: 10.1056/NEJM199205143262003 – year: 2019 ident: 10.1016/j.nutres.2019.10.009_bb0125 article-title: Impaired glucagon suppression and reduced insulin sensitivity in subjects with prediabetes undergoing atorvastatin therapy publication-title: Eur J Endocrinol doi: 10.1530/EJE-19-0173 – volume: 3 start-page: e78 year: 2013 ident: 10.1016/j.nutres.2019.10.009_bb0155 article-title: Acute sleep deprivation delays the glucagon-like peptide 1 peak response to breakfast in healthy men publication-title: Nutr Diabetes doi: 10.1038/nutd.2013.20 – volume: 15 start-page: 186 year: 2016 ident: 10.1016/j.nutres.2019.10.009_bb0055 article-title: Effects of ghrelin in energy balance and body weight homeostasis publication-title: Hormones (Athens) doi: 10.14310/horm.2002.1672 – volume: 32 start-page: 1171 year: 2018 ident: 10.1016/j.nutres.2019.10.009_bb0135 article-title: GLP-1, a powerful physiological incretin: an update publication-title: J Biol Regul Homeost Agents – volume: 363 start-page: k4583 year: 2018 ident: 10.1016/j.nutres.2019.10.009_bb0150 article-title: Effects of a low carbohydrate diet on energy expenditure during weight loss maintenance: randomized trial publication-title: BMJ doi: 10.1136/bmj.k4583 – volume: 57 start-page: 119 year: 2010 ident: 10.1016/j.nutres.2019.10.009_bb0105 article-title: Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes publication-title: Endocr J doi: 10.1507/endocrj.K09E-269 – volume: 130 start-page: 79 year: 2016 ident: 10.1016/j.nutres.2019.10.009_bb0140 article-title: The regulation of function, growth and survival of GLP-1-producing L-cells publication-title: Clin Sci (Lond) doi: 10.1042/CS20150154 – volume: 93 start-page: 217 year: 2018 ident: 10.1016/j.nutres.2019.10.009_bb0075 article-title: The role of glucagon in the pathophysiology and treatment of type 2 diabetes publication-title: Mayo Clin Proc doi: 10.1016/j.mayocp.2017.12.003 – volume: 14 start-page: 390 year: 2018 ident: 10.1016/j.nutres.2019.10.009_bb0030 article-title: Glucagon-like peptide 1 in health and disease publication-title: Nat Rev Endocrinol doi: 10.1038/s41574-018-0016-2 – volume: 15 start-page: 123 year: 2016 ident: 10.1016/j.nutres.2019.10.009_bb0085 article-title: Glucagon and heart in type 2 diabetes: new perspectives publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-016-0440-3 – volume: 65 start-page: 3473 year: 2016 ident: 10.1016/j.nutres.2019.10.009_bb0115 article-title: Insulin resistance is accompanied by increased fasting glucagon and delayed glucagon suppression in individuals with normal and impaired glucose regulation publication-title: Diabetes doi: 10.2337/db16-0240 – volume: 100 start-page: 42 year: 2018 ident: 10.1016/j.nutres.2019.10.009_bb0080 article-title: Glucagon receptor signaling in metabolic diseases publication-title: Peptides doi: 10.1016/j.peptides.2017.11.016 |
SSID | ssj0017133 |
Score | 2.247571 |
Snippet | Little is known about postprandial release of serum ghrelin, glucagon, and glucagon-like peptide-1 (GLP-1) in relation with differing fasting insulin levels.... |
SourceID | swepub proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 111 |
SubjectTerms | beverages blood serum Carbohydrate content carbohydrate metabolism disorders carbohydrates cross-over studies energy fasting Ghrelin Glucagon Glucagon-like peptide-1 insulin insulin resistance Meal distribution men protein content Satiety statistical models statistics women |
Title | Subjects with high fasting insulin also have higher postprandial GLP-1 and glucagon levels than controls with lower insulin |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0271531719305214 https://dx.doi.org/10.1016/j.nutres.2019.10.009 https://www.ncbi.nlm.nih.gov/pubmed/31759769 https://www.proquest.com/docview/2317971574 https://www.proquest.com/docview/2352445701 https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-163259 |
Volume | 72 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVESC databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier) customDbUrl: eissn: 1879-0739 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017133 issn: 1879-0739 databaseCode: GBLVA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier ScienceDirect Freedom Collection Journals customDbUrl: eissn: 1879-0739 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017133 issn: 1879-0739 databaseCode: AIKHN dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Complete Freedom Collection [SCCMFC] customDbUrl: eissn: 1879-0739 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017133 issn: 1879-0739 databaseCode: ACRLP dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection customDbUrl: eissn: 1879-0739 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017133 issn: 1879-0739 databaseCode: .~1 dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1879-0739 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017133 issn: 1879-0739 databaseCode: AKRWK dateStart: 19810101 isFulltext: true providerName: Library Specific Holdings |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLWm7YUXBBsfHWwyEtqb1zix4-ax2hjlq0KCob1ZjutsmUJStSkSmrTfzr2JHQkQDPHWOLbT1NfXx7fnHhPyMgMHOLHcMdSeYyKGT5lylqk0sxMA5JEzuFH8ME9n5-LthbzYIichFwZpld739z6989a-ZOx_zfGyLMefYEMF05UrgCCYgYqaoKj-BTZ9fDvQPDhuwro4i-IMa4f0uY7jVW8wIQMJXtlxx_HK_rQ8_Q4_f9EW7dajswfkvgeSdNp_14dky9W7ZG9awyb663d6RDtqZxcz3yWj09K1UOZFQCs6Dxr8e-QGXAfGYtYUQ7IU5YtpYdbIhqaeqE7BRBt6Zb657rZb0WWzbpcrzIiBzl6__8g4hQuK_Hdz2dS0QirSmmJYnnoyvO-_wlPZQsePyPnZq88nM-ZPZGBWJnHLikgaaQoj3MRFqNUmVFpYk3Kb2wWPiyTOCgeIRtg4tUUOaKIA_JVHViDfHLzJY7JdN7V7SqiQE5VwpyS3Tihp88jE3GTCLsTC8kSOSBIGQlsvV46nZlQ68NKudT98GocPS2H4RoQNrZa9XMcd9WUYYx1SUcF5alhP7minhnY_mes_tHwRTEnDTMa_Z0ztmg1UAuvMwKSV-FsdCXhMqoiPyJPeDof3RCQI4BKecNQb5nAHJcRPyy9T3awudVVuNIBw2Pbu__dLPCP38Kqn9Twn2-1q4w4AnLX5YTf7DsnO9M272fwHhkE6aw |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwED6N7gFeEGzAyk8job2FxokdN4_VxuhYVyGxob1ZruuMoJBUbYqE-Oe5S5xIgGCIt8T2OU3vfP7sfHcGeJWiAxxb7gLKPReICK9S5WygktSOEZCHztBC8XyeTC_Fuyt5tQNHXSwM0Sq97299euOtfcnI_5ujVZ6PPuCCCocrVwhBKAJV3IJdIdEnD2B3cno2nfcfE2gd1my1KB6QQBdB19C8yi3FZBDHK33d0LzSP81QvyPQX9KLNlPSyT2467Ekm7Q_9z7suHIP9iclrqO_fGOHrGF3NtvmezA8zl2NZT4PaMHmXRr-ffiO3oO2YzaMdmUZZTBmmdkQIZp5rjpDK63YJ_PVNdVuzVbVpl6tKSgGO3s7ex9whjeMKPDmuipZQWykDaOdeeb58L7_gg5m6zp-AJcnby6OpoE_lCGwMo7qIAulkSYzwo1dSOnahEoyaxJuF3bJoyyO0swhqBE2Smy2QECRIQRbhFYQ5RwdykMYlFXpDoAJOVYxd0py64SSdhGaiJtU2KVYWh7LIcSdIrT1Gcvp4IxCd9S0z7pVnyb1USmqbwhBL7VqM3bc0F52OtZdNCr6T41Tyg1yqpf7yWL_QfJlZ0oaBzN9oTGlq7bYCK0zRatW4m9tJEIyqUI-hEetHfbvSWAQ8SU-4bA1zL6Gsogf5x8nulpf6yLfasThuPJ9_N8v8QJuTy_OZ3p2Oj97AneopmX5PIVBvd66Z4jV6sVzPxZ_ABF0PRY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Subjects+with+high+fasting+insulin+also+have+higher+postprandial+GLP-1+and+glucagon+levels+than+controls+with+lower+insulin&rft.jtitle=Nutrition+research+%28New+York%2C+N.Y.%29&rft.au=Albinsson-Stenholm%2C+Erina&rft.au=Bergs%C3%A9n%2C+Johannes&rft.au=Ingves%2C+Simon&rft.au=Vilhelmsson%2C+Nathalie&rft.date=2019-12-01&rft.issn=0271-5317&rft.volume=72&rft.spage=111&rft.epage=120&rft_id=info:doi/10.1016%2Fj.nutres.2019.10.009&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_nutres_2019_10_009 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0271-5317&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0271-5317&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0271-5317&client=summon |